GGrantIndex
Sort

53,477 grants matching addiction

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Abusers

$679,807
Stacey C Sigmon · University Of Vermont & St Agric College · U54 · FY2022 · DA

Role of cannabis on HIV-related cognitive impairment: a brain connectomics study

$679,784
Christina S Meade · Duke University · R01 · FY2020 · DA

Project 3: Adolescent smoking: Vulnerability to Tobacco Use and Market p265-296

$679,736
Jonathan M. Samet · University Of Southern California · P50 · FY2016 · CA

Mechanisms of maladaptive memory formation and suppression in a preclinical model of the comorbidity between PTSD and addiction

$679,736
Kennon Matthew Lattal · Oregon Health & Science University · R01 · FY2022 · DA

Effects of Prenatal Opiates on Infant Brain and Neurobehavioral Development

$679,645
Karen M Grewen · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DA

TREATING COCAINE ABUSE: A BEHAVIORAL APPROACH

$679,601
University Of Vermont &St Agric College · R01 · FY2000 · DA

Molecular, anatomic, and functional characterization of midbrain dopamine neuron subtypes

$679,543
Daniel A Dombeck · Northwestern University · R01 · FY2021 · MH

Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs

$679,534
Michael Parks Bogenschutz · New York University School Of Medicine · R01 · FY2016 · DA

Administrative Core

$679,386
Wenqin Luo · University Of Pennsylvania · U19 · FY2023 · NS

Evaluating New Nicotine Standards for Cigarettes - Administrative Core

$679,385
Eric Christian Donny · Wake Forest University Health Sciences · U54 · FY2020 · DA

Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention

$679,384
Brian R. Edlin · Suny Downstate Medical Center · R01 · FY2011 · DA

Alcohol and HIV Risk Reduction in St. Petersburg, R.F.

$679,357
Nadia Abdala · Yale University · R01 · FY2009 · AA

Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology

$679,275
Laura M Bohn · Scripps Florida · R01 · FY2013 · DA

Impact of e-cigarette prevention messages on adolescents

$679,264
Seth Michael Noar · Univ Of North Carolina Chapel Hill · R01 · FY2023 · DA

Neurobiological susceptibility to peer influence and drug use in adolescence

$679,252
Eva Haimo Telzer · Univ Of North Carolina Chapel Hill · R01 · FY2023 · DA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$679,225
James L. Sorensen · University Of California, San Francisco · UG1 · FY2018 · DA

Evaluation of Opioid Antagonist Activity in Humans

$679,189
Eric C Strain · Johns Hopkins University · R01 · FY2007 · DA

Dopamine and Frontostriatal Function

$679,105
Mark D'esposito · University Of California Berkeley · R01 · FY2014 · DA

Epigenetic mechanisms of sustained transcription across cocaine abstinence

$679,084
Elizabeth A Heller · University Of Pennsylvania · R01 · FY2021 · DA

Randomized trial of a data-driven technical assistance system for drug prevention coalitions

$679,082
Louis Davis Brown · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DA

Methamphetamine Abuse, Inhibitory Control: Implications for Treatment

$679,004
Edythe D London · University Of California Los Angeles · P20 · FY2006 · DA

NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users

$678,940
Luis J. Montaner · Wistar Institute · R01 · FY2012 · DA

Neural Response to Risky Decision Making in Youth at High Risk for Substance Use Disorders and HIV

$678,820
Leslie A. Hulvershorn · Indiana University Indianapolis · R01 · FY2016 · DA

Heroin in Transition

$678,747
Daniel H Ciccarone · University Of California, San Francisco · R01 · FY2019 · DA

Employment-Based Depot Naltrexone Clinical Trial

$678,745
Johns Hopkins University · R01 · FY2005 · DA